UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000048079
Receipt No. R000052729
Scientific Title Comparative study of the efficacy of prostaglandin-E major urinary metabolite with other biomarkers for the determination of activity of inflammatory bowel diseases
Date of disclosure of the study information 2022/06/16
Last modified on 2022/06/16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Comparative study of the efficacy of prostaglandin-E major urinary metabolite with other biomarkers for the determination of activity of inflammatory bowel diseases
Acronym COMPROMISE study
Scientific Title Comparative study of the efficacy of prostaglandin-E major urinary metabolite with other biomarkers for the determination of activity of inflammatory bowel diseases
Scientific Title:Acronym COMPROMISE study
Region
Japan

Condition
Condition Inflammatory bowel disease
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare the efficacy of prostaglandin-E major urinary metabolite (PGE-MUM) with other biomarkers (including leucin rich alfa glycoprotein and fecal calprotectin) for the determination of the activity of inflammatory bowel disease
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Others
Developmental phase Not applicable

Assessment
Primary outcomes To analyze the equality of the accuracy of PGE-MUM for the determination of activity of inflammatory bowel disease with leucin rich alfa glycoprotein and fecal calprotectin.
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Patients with ulcerative colitis or crohn's disease, who scheduled to undergo colonoscopy or small intestinal endoscopy.
Key exclusion criteria Patients with:
post total colectomy,
post intestinal surgery within 6 months,
using oral purgatives
using nonsteroidal anti-inflammatory drugs,
using medication associated with prostaglandin,
severe renal dysfuntion
Target sample size 150

Research contact person
Name of lead principal investigator
1st name Masayuki
Middle name
Last name Saruta
Organization The Jikei University School of Medicine
Division name Division of Gastroenterology and Hepatology
Zip code 105-8461
Address 3-25-8, Nishi-shinbasshi, Minato-ku
TEL +81334331111
Email m.saruta@jikei.ac.jp

Public contact
Name of contact person
1st name Toshiyuki
Middle name
Last name Sakurai
Organization The JIKEI university school of medicine
Division name Division of Gastroenterology and Hepatology
Zip code 105-8461
Address 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo, JAPAN
TEL +81334331111
Homepage URL
Email to-sakurai@jikei.ac.jp

Sponsor
Institute The Jikei University School of Medicine
Institute
Department

Funding Source
Organization The Jikei University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization The JIKEI university school of medicine
Address 3-25-8, Nishi-shinbashi, Minato-ku, Tokyo
Tel +81334331111
Email to-sakurai@jikei.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京慈恵会医科大学附属病院

Other administrative information
Date of disclosure of the study information
2022 Year 06 Month 16 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2021 Year 10 Month 13 Day
Date of IRB
2021 Year 10 Month 13 Day
Anticipated trial start date
2021 Year 10 Month 13 Day
Last follow-up date
2022 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Cross-sectional study

Management information
Registered date
2022 Year 06 Month 16 Day
Last modified on
2022 Year 06 Month 16 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052729

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.